Last year, we brought together social impact leaders from top pharmaceutical and biopharma companies to explore the unique challenges and opportunities shaping the industry.

This year Rashad Burgess, head of Corporate Responsibility at Gilead, and NationSwell are reconvening this group to explore the most pressing needs attendees are facing in navigating the changing internal and external environments, and identify commonalities through the conversation that we can address through action afterwards.

Note: this conversation is distinct from ongoing discussions in the Health Action Collaborative, as it is focused on the leadership experience and context vs. issue area advancement.

To encourage open and candid discussion, this event follows the Chatham House Rule – attendees may share insights from the conversation but cannot attribute statements to specific individuals or organizations. This ensures a trusted space for thoughtful dialogue and deeper insights.